May 13, 2020
In her role as Vice President of Strategy, Lisa is focused on building sustainable growth for the company. She leverages her experience in global product commercialization to help forge long-term collaboration and productive client relationships, with a core focus on Ximedica’s critical, strategic partners.
Lisa has 25+ years of international commercialization of healthcare and consumer products with companies in the US, Europe and China. As co-founder of a healthcare management consulting firm, Lisa led projects involving commercialization strategy, portfolio assessments and due diligence, with special emphasis on medtech innovation. Clients and employers have included Procter & Gamble, MedImmune, Agilent and Emergent Biosolutions. Lisa also gained valuable hands-on startup experience as a founding executive of a commercialized medical device startup. An active member of the medtech startup and investor community, Lisa is as an advisor to many startups and accelerators including CLSI’s FAST program, Medtech Innovator and UCSF Health Hub. She also serves on the board of the California Life Sciences Institute, the innovation arm of California Life Sciences Association, and as an advisor to the Cleveland Clinic Medtech Advisory Board, UCLA’s Technology Ventures Group Advisory Board and Red Crow Angel Investor platform.